[go: up one dir, main page]

WO2003065044A8 - Diagnostics and therapeutics for diseases associated with gpr72 - Google Patents

Diagnostics and therapeutics for diseases associated with gpr72

Info

Publication number
WO2003065044A8
WO2003065044A8 PCT/EP2003/000476 EP0300476W WO03065044A8 WO 2003065044 A8 WO2003065044 A8 WO 2003065044A8 EP 0300476 W EP0300476 W EP 0300476W WO 03065044 A8 WO03065044 A8 WO 03065044A8
Authority
WO
WIPO (PCT)
Prior art keywords
disorders
diseases
gpr72
nervous system
therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/000476
Other languages
French (fr)
Other versions
WO2003065044A3 (en
WO2003065044A2 (en
Inventor
Stefan Golz
Ulf Brueggemeier
Andreas Geerts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2003205627A priority Critical patent/AU2003205627A1/en
Publication of WO2003065044A2 publication Critical patent/WO2003065044A2/en
Publication of WO2003065044A8 publication Critical patent/WO2003065044A8/en
Publication of WO2003065044A3 publication Critical patent/WO2003065044A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Diagnostics and therapeutics for diseases associated with GPR72Abstract of DisclosureThe invention also provides a human GPR72 which is associated with the hematological diseases, cardiovascular diseases, disorders of the peripheral nervous system, disorders of the central nervous system, COPD, asthma, genito-urological disorders, or inflammation diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of hematological diseases, cardiovascular diseases, disorders of the peripheral nervous system, disorders of the central nervous system, COPD, asthma, genito-urological disorders, or inflammation diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of GPR72 as well as pharmaceutical compositions comprising such compounds.
PCT/EP2003/000476 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with gpr72 Ceased WO2003065044A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003205627A AU2003205627A1 (en) 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with gpr72

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02001941.0 2002-02-01
EP02001941 2002-02-01

Publications (3)

Publication Number Publication Date
WO2003065044A2 WO2003065044A2 (en) 2003-08-07
WO2003065044A8 true WO2003065044A8 (en) 2003-12-24
WO2003065044A3 WO2003065044A3 (en) 2004-03-04

Family

ID=27635779

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/000476 Ceased WO2003065044A2 (en) 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with gpr72

Country Status (2)

Country Link
AU (1) AU2003205627A1 (en)
WO (1) WO2003065044A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007035551A1 (en) * 2005-09-19 2007-03-29 Eisai R & D Management Co., Ltd. Methods for identifying gpr83 agonists and antagonists capable of modulating regulatory t cell function
EP1867994B1 (en) * 2006-06-13 2012-09-26 Euroscreen S.A. Ligand for G-protein coupled receptor GPR72 and uses thereof
CA2589393C (en) 2006-06-13 2016-04-12 Euroscreen S.A. Ligand for g-protein coupled receptor gpr72 and uses thereof
US20090280092A1 (en) * 2007-01-22 2009-11-12 Wiebke Hansen G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
ES2825718T3 (en) 2007-02-01 2021-05-17 Univ Der Johannes Gutenberg Univ Mainz Specific activation of a regulatory T cell and its use for the treatment of asthma, allergic diseases, autoimmune diseases, graft rejection and for the induction of tolerance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1165147A (en) * 1996-02-07 1997-11-19 武田药品工业株式会社 Guanine nudeotide combined protein coupled receptor proteins, their production and use
CA2231754A1 (en) * 1997-05-07 1998-11-07 Smithkline Beecham Corporation A novel human g-protein coupled receptor hcept09
SE9904660D0 (en) * 1999-12-17 1999-12-17 Astra Pharma Inc Novel assays

Also Published As

Publication number Publication date
WO2003065044A3 (en) 2004-03-04
AU2003205627A1 (en) 2003-09-02
WO2003065044A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
WO2003082314A3 (en) Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
WO2004042389A3 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
WO2003081258A3 (en) Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
WO2003074069A3 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
WO2003093816A3 (en) Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
WO2003065044A8 (en) Diagnostics and therapeutics for diseases associated with gpr72
WO2004042402A3 (en) Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
WO2004071378A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
WO2004038405A3 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
WO2005106491A3 (en) Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
WO2003083135A3 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
WO2003066077A3 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
WO2004071394A3 (en) Diagnostics and therapeutics for diseases associated with hm74
WO2003100433A3 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
WO2003096020A3 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
WO2003081257A3 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
WO2004038421A3 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
WO2003081256A3 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21)
WO2004042390A3 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
WO2004071392A8 (en) Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4)
WO2003100435A3 (en) Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
WO2004042405A3 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)
WO2004082566A3 (en) Diagnostics and therapeutics for diseases associated with complement component 3a receptor 1 (c3ar1)
WO2004015427A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19)
WO2003100434A3 (en) Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 32/2003 UNDER (22) REPLACE "2 JANUARY 2003 (02.01.2003)" BY "20 JANUARY 2003 (20.01.2003)"

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP